Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial

Mônica R. Gadelha(Hospital Universitário Clementino Fraga Filho), Marcello D. Bronstein(Universidade de São Paulo), Thierry Brue(Assistance Publique Hôpitaux de Marseille), Mihail Coculescu, Maria Fleseriu(Neurological Surgery), Mirtha Guitelman(El Hospital General de Agudos Carlos G. Durand), Vyacheslav Pronin(Sechenov University), Gérald Raverot(Hospices Civils de Lyon), Ilan Shimon(Tel Aviv University), Kayo Kodama Lievre(Novartis (Switzerland)), Juergen Fleck(Novartis (Switzerland)), Mounir Aout(Novartis (Switzerland)), Alberto M Pedroncelli(Novartis (Switzerland)), Annamaria Colao(University of Naples Federico II)
The Lancet Diabetes & Endocrinology
September 24, 2014
Cited by 400

Abstract


Related Papers

No related papers found

Powered by citation graph analysis